Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Eevia receive sales order for 827 KSEK (73 KEUR)

Eevia Health Plc (”Eevia” or ”The Company”) has received a sales order for 73 KEUR (827 KSEK) from a large international ingredient company for Feno-Myrtillus® 25 organic (bilberry extracts).Eevia received the sales order from a large international nutraceutical ingredients house, which markets ingredients on three different continents and multiple application areas.  The customer has a focus on sustainability and therefore products made in Finland close to the source is favored. The product is Feno-Myrtillus® 25 Organic and the value of the start order is 73 KEUR (827 KSEK). This is a

Wihlborgs welcomes law firm Delphi to Malmö’s historic building Börshuset

Delphi will become a part of a new era for Börshuset (Börshuset 1) when the law firm moves in to 1,600 square metres in 2026. The ongoing renovation will be completed by the end of 2025 and will preserve and highlight the building’s original character, while concurrently creating an attractive space for companies, Malmö residents and visitors.Delphi is a business law firm with offices in Malmö, Gothenburg, Stockholm and Linköping. The firm is now moving to offices on three floors of Börshuset, with access to the roof terrace and a view over the canal and central Malmö. Occupancy begins in

SEB develops its organisational structure to support its long-term strategic direction

SEB develops its divisional structure, consolidating its wealth and asset management operations into one division, and implements a new Chief Operating Officer (COO) function. The changes are intended to better equip SEB’s organisation to continue delivering on its long-term strategy, further strengthening customer focus and enabling faster time to market.  “To continue our successful journey and deliver on our 2030 Strategy, we are now adjusting our operating model to reflect our long-term strategic priorities. Through these changes, we address competition, the increasing pace of

Uniwater enters agreement to acquire Biowater Technology – expands geographical reach and specialist expertise in water treatment

Uniwater has entered into an agreement to acquire Biowater Technology, a Norwegian specialist in innovative water treatment technologies and projects. The acquisition of Biowater Technology is the fifth addition to the Uniwater group portfolio in 2024.Biowater Technology is an engineering and construction company specialized in wastewater treatment, based in Tonsberg, Norway.  With the acquisition of Biowater Technology, Uniwater expands its offering into new markets and adds cutting-edge solutions for water and wastewater treatment to the portfolio. – We are thrilled to welcome Biowater

New understanding of the limits on nano-noise

Thanks to nanoscale devices as small as human cells, researchers can create groundbreaking material properties, leading to smaller, faster, and more energy-efficient electronics. However, to fully unlock the potential of nanotechnology, addressing noise is crucial. A research team at Chalmers University of Technology, in Sweden, has taken a significant step toward unraveling fundamental constraints on noise, paving the way for future nanoelectronics. Nanotechnology is rapidly advancing, capturing widespread interest across industries such as communications and energy

DBP International AB: transition of the SI053 clinical trials protocol to a new Clinical Trial Information System has been completed

Double Bond Pharmaceutical International AB (publ) ("DBP" or "The Company", org. No. 556991-6082) is pleased to announce the successful transition of its clinical study "An open-label dose escalation study to estimate the maximum tolerated dose (MTD), identify dose-limiting toxicities (DLTs), and study pharmacokinetics following a single dose of intracranially administered temozolomide-based SI-053 as an add-on to the current standard of care (SoC) in adult patients with newly diagnosed glioblastoma (GBM)," to a new Clinical Trial Information System (CTIS). Adoption to this on-line system

Nitro Games Oyj: Managers’ Transactions

Person subject to the notification requirementName:                          Antti VillanenPosition:                                   Member of the Board Notification type:                      Initial notificationIssuer Name:                             Nitro Games OyjLEI:                             743700XPEJZPMWDULF59Transaction detailsTransaction date:                       2024-09-16 Venue:                         Outside a trading venue ISIN:                            FI4000242961 Nature of transaction:                Purchase Instrument:

Nitro Games Oyj: Managers’ Transactions

Person subject to the notification requirementName:                          Jussi TähtinenPosition:                                   CEO Notification type:                      Initial notificationIssuer Name:                             Nitro Games OyjLEI:                             743700XPEJZPMWDULF59Transaction detailsTransaction date:                       2024-09-16 Venue:                         Outside a trading venue ISIN:                            FI4000242961 Nature of transaction:                Purchase Instrument:

Nitro Games Oyj: Managers’ Transactions

Person subject to the notification requirementName:                          Matti NikkolaPosition:                                   CFO Notification type:                      Initial notificationIssuer Name:                             Nitro Games OyjLEI:                             743700XPEJZPMWDULF59Transaction detailsTransaction date:                       2024-09-16 Venue:                         Outside a trading venue ISIN:                            FI4000242961 Nature of transaction:                Purchase Instrument:

Nitro Games Oyj: Managers’ Transactions

Person subject to the notification requirementName:                          Samppa RönkäPosition:                                   CTO Notification type:                      Initial notificationIssuer Name:                             Nitro Games OyjLEI:                             743700XPEJZPMWDULF59Transaction detailsTransaction date:                       2024-09-16 Venue:                         Outside a trading venue ISIN:                            FI4000242961 Nature of transaction:                Purchase Instrument:

Nitro Games Oyj: Managers’ Transactions

Person subject to the notification requirementName:                          Nordisk Games A/SPosition:                                   The closely associated person Person discharging managerial responsibilities in issuer:                        Morgan Habedank                                     Member of the Board Notification type:                      Initial notificationIssuer Name:                             Nitro Games OyjLEI:                             743700XPEJZPMWDULF59Transaction detailsTransaction date:                       2024-09-16 Venue:

Nitro Games Oyj: Managers’ Transactions

Person subject to the notification requirementName:                          Advenimus ABPosition:                                   The closely associated person Person discharging managerial responsibilities in issuer:                        Susana Meza Graham                                     Member of the Board Notification type:                      Initial notificationIssuer Name:                             Nitro Games OyjLEI:                             743700XPEJZPMWDULF59Transaction detailsTransaction date:                       2024-09-16 Venue:

Nitro Games Oyj: Managers’ Transactions

Person subject to the notification requirementName:                          Johan BiehlPosition:                                   Chairman of the Board Notification type:                      Initial notificationIssuer Name:                             Nitro Games OyjLEI:                             743700XPEJZPMWDULF59Transaction detailsTransaction date:                       2024-09-16 Venue:                         Outside a trading venue ISIN:                            FI4000242961 Nature of transaction:                Purchase Instrument:

Nitro Games Oyj: Nordisk Games has sold 6.5 million shares in Nitro Games to current shareholders and new investors

Nitro Games Oyj (“Nitro Games” or the “Company”) has been informed that Nordisk Games A/S (“Nordisk Games”) has sold its entire holding of 6,492,636 shares in Nitro Games to current shareholders in the Company, including members of the board and management, as well as some new external investors. The transaction corresponds to approximately 26.0 per cent of the outstanding shares and votes in Nitro Games, and the sale was executed at a price of SEK 1.50 per share which corresponds to a total purchase price of approximately SEK 9.7 million. The transaction was executed as a block trade,

Immunovia presents data from model development study at 2024 AACR Advances in Pancreatic Cancer medical conference

LUND (SWEDEN) – Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, today presented detailed model-development study results at the AACR Special Conference in Cancer Research: Advances in Pancreatic Cancer (abstract #B027).   Immunovia shared results from the model development study of its next-generation test to detect stage 1 and 2 pancreatic cancer. The company disclosed its method for selecting the biomarkers that comprise the test, the construction of the test algorithm, and the test’s performance and stability. In the study of 623 patient samples,

Repurchases of shares in Hoist Finance during week 37, 2024

PRESS RELEASEStockholm 16 September 2024   During the period 09 September 2024 – 13 September 2024 Hoist Finance AB (publ) (LEI code: 549300NPK3FB2BEL4D08) (”Hoist Finance”) has repurchased in total 162,000 own shares (ISIN: SE0006887063), as part of the repurchase programme initiated by the Board of Directors. The repurchases form part of the repurchase programme of a maximum of 10 percent of the total number of shares in the company for a total amount of not more than SEK 100,000,000 that Hoist Finance announced on 25 July 2024. The repurchase programme runs during the

Director/PDMR Shareholding

MITON UK MICROCAP TRUST PLC LEI: 21380048Q8UABVMAG916 Notification of transactions by Persons Discharging Managerial Responsibilities (‘PDMRs’) and persons closely associated with them 1. Details of the person discharging managerial responsibilities/person closely associateda) Name Mr Peter Dicks2. Reason for the notificationa) Position/Status Directorb) Initial Notification/Amendment Initial notification3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or

Relais Group Plc: Share Repurchase 16.9.2024

Relais Group Plc  ANNOUNCEMENT  16.9.2024 Relais Group Plc: Share Repurchase 16.9.2024 In the Helsinki Stock Exchange Trade date           16.9.2024Bourse trade         BuyShare                  RELAISAmount             570 SharesAverage price/ share    14,9000 EURTotal cost            8 493,00 EUR Relais Group Plc now holds a total of 60 328 sharesincluding the shares repurchased on 16.9.2024 On behalf of Relais Group Plc Nordea Bank Oyj Janne

There are no items matching the current filter
There are no more items matching the current filter
Back to top